» Articles » PMID: 38909998

A Randomized, Placebo-controlled Study of Chitosan Gel for the Treatment of Chronic Diabetic Foot Ulcers (the CHITOWOUND Study)

Overview
Specialty Endocrinology
Date 2024 Jun 23
PMID 38909998
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: To assess the efficacy of a chitosan-based gel (ChitoCare) for the treatment of non-healing diabetic foot ulcers (DFUs).

Research Design And Methods: Forty-two patients with chronic DFUs were randomized to the ChitoCare or placebo gel for a 10-week treatment period and 4-week follow-up. The primary study end point was the rate of complete wound closure at week 10, presented as relative rate.

Results: Thirty patients completed the 10-week treatment and 28 completed the 4-week follow-up. The ChitoCare arm achieved 16.7% complete wound closure at week 10 vs 4.2% in the placebo arm (p=0.297), 92.0% vs 37.0% median relative reduction in wound surface area from baseline at week 10 (p=0.008), and 4.62-fold higher likelihood of achieving 75% wound closure at week 10 (p=0.012). Based on the results of the Bates-Jensen Wound Assessment Tool, the wound state at week 10 and the relative improvement from the baseline were significantly better (median 20 vs 24 points, p=0.018, and median 29.8% vs 3.6%, p=0.010, respectively).

Conclusions: ChitoCare gel increased the rate of the DFU healing process. Several secondary end points significantly favored ChitoCare gel.

Trial Registration Number: NCT04178525.

Citing Articles

An Overview of Recent Clinical Trials for Diabetic Foot Ulcer Therapies.

Ganesan O, Orgill D J Clin Med. 2025; 13(24.

PMID: 39768578 PMC: 11676782. DOI: 10.3390/jcm13247655.


Adjuvant local antibiotic therapy in the management of diabetic foot osteomyelitis.

Metaoy S, Rusu I, Pillai A Clin Diabetes Endocrinol. 2024; 10(1):51.

PMID: 39681930 PMC: 11648298. DOI: 10.1186/s40842-024-00200-w.

References
1.
Rodriguez-Rodriguez N, Martinez-Jimenez I, Garcia-Ojalvo A, Mendoza-Mari Y, Guillen-Nieto G, Armstrong D . Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients. MEDICC Rev. 2021; 24(1):44-58. DOI: 10.37757/MR2021.V23.N3.8. View

2.
Aldana P, Khachemoune A . Diabetic Foot Ulcers: Appraising Standard of Care and Reviewing New Trends in Management. Am J Clin Dermatol. 2019; 21(2):255-264. DOI: 10.1007/s40257-019-00495-x. View

3.
Wagner Jr F . The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981; 2(2):64-122. DOI: 10.1177/107110078100200202. View

4.
Margolis D, Allen-Taylor L, Hoffstad O, Berlin J . Healing diabetic neuropathic foot ulcers: are we getting better?. Diabet Med. 2005; 22(2):172-6. DOI: 10.1111/j.1464-5491.2004.01375.x. View

5.
Peh K, Khan T, Chng H . Mechanical, bioadhesive strength and biological evaluations of chitosan films for wound dressing. J Pharm Pharm Sci. 2001; 3(3):303-11. View